IIM
LLY icon

Intact Investment Management’s Eli Lilly LLY Stock Holding History

Intact Investment Management’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-3,180
Closed -$3.25M – 252
2026
Q1 		$2.92M Buy
3,180
+150
+5% +$152K 0.08% 167
2025
Q4 		$3.26M Sell
3,030
-460
-13% -$440K 0.09% 157
2025
Q3 		$2.66M Buy
3,490
+110
+3% +$81.9K 0.08% 164
2025
Q2 		$2.63M Buy
3,380
+710
+27% +$552K 0.09% 172
2025
Q1 		$2.21M Buy
2,670
+230
+9% +$191K 0.08% 177
2024
Q4 		$1.88M Sell
2,440
-140
-5% -$116K 0.07% 180
2024
Q3 		$2.29M Buy
2,580
+560
+28% +$503K 0.08% 173
2024
Q2 		$1.83M Buy
2,020
+620
+44% +$496K 0.07% 171
2024
Q1 		$1.09M Sell
1,400
-200
-13% -$142K 0.04% 196
2023
Q4 		$933K Hold
1,600
– – 0.04% 197
2023
Q3 		$859K Sell
1,600
-800
-33% -$412K 0.04% 196
2023
Q2 		$1.13M Buy
2,400
+300
+14% +$126K 0.05% 189
2023
Q1 		$721K Buy
2,100
+500
+31% +$169K 0.03% 194
2022
Q4 		$585K Buy
1,600
+600
+60% +$213K 0.03% 201
2022
Q3 		$324K Buy
+1,000
New +$317K 0.01% 247
2022
Q2 		– Sell
-1,500
Closed -$430K – 258
2022
Q1 		$430K Buy
+1,500
New +$386K 0.01% 247
2021
Q1 		– Sell
-22,400
Closed -$3.78M – 249
2020
Q4 		$3.78M Buy
22,400
+6,400
+40% +$956K 0.12% 138
2020
Q3 		$2.36M Hold
16,000
– – 0.08% 154
2020
Q2 		$2.62M Buy
16,000
+2,600
+19% +$399K 0.1% 138
2020
Q1 		$1.86M Hold
13,400
– – 0.08% 153
2019
Q4 		$1.76M Hold
13,400
– – 0.06% 166
2019
Q3 		$1.5M Hold
13,400
– – 0.05% 173
2019
Q2 		$1.48M Hold
13,400
– – 0.05% 169
2019
Q1 		$1.74M Buy
+13,400
New +$1.63M 0.06% 161
2018
Q2 		– Sell
-2,800
Closed -$217K – 277
2018
Q1 		$217K Buy
+2,800
New +$225K 0.01% 229
2017
Q2 		– Sell
-9,900
Closed -$833K – 268
2017
Q1 		$833K Sell
9,900
-7,900
-44% -$633K 0.03% 134
2016
Q4 		$1.31M Sell
17,800
-5,800
-25% -$432K 0.05% 134
2016
Q3 		$1.89M Hold
23,600
– – 0.07% 124
2016
Q2 		$1.86M Sell
23,600
-4,200
-15% -$316K 0.08% 125
2016
Q1 		$2M Sell
27,800
-35,100
-56% -$2.66M 0.08% 123
2015
Q4 		$5.3M Buy
62,900
+2,400
+4% +$199K 0.24% 74
2015
Q3 		$5.06M Sell
60,500
-2,400
-4% -$203K 0.23% 74
2015
Q2 		$5.25M Sell
62,900
-15,900
-20% -$1.21M 0.22% 79
2015
Q1 		$5.72M Sell
78,800
-4,300
-5% -$306K 0.23% 78
2014
Q4 		$5.73M Buy
83,100
+35,300
+74% +$2.38M 0.23% 78
2014
Q3 		$3.1M Buy
47,800
+24,120
+102% +$1.53M 0.13% 88
2014
Q2 		$1.47M Hold
23,680
– – 0.06% 93
2014
Q1 		$1.39M Buy
+23,680
New +$1.32M 0.06% 92

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
SC
Sapient Capital Indianapolis, Indiana $7.64B AUM 51.51% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return
ONB
Old National Bancorp Evansville, Indiana $5.02B AUM 25.65% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return
GIM
Goelzer Investment Management Carmel, Indiana $2.29B AUM 39.12% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Intact Investment Management's LLY Position: Q2 2026 in Review

Intact Investment Management sold out of Eli Lilly (LLY) in Q2 2026, closing a stake of 3,180 shares — an estimated $3.25M sold.

Intact Investment Management first reported a position in LLY in Q1 2014 and held it in 38 quarters. The position peaked at $5.73M in Q4 2014. 1,800 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Intact Investment Management reported no remaining Eli Lilly position as of Q2 2026 after selling out during the quarter.
  • Intact Investment Management sold 3,180 Eli Lilly shares in Q2 2026, an estimated $3.25M.
  • Intact Investment Management first reported a position in Eli Lilly in Q1 2014 and held it in 38 quarters.
  • Intact Investment Management's Eli Lilly position peaked at $5.73M in Q4 2014.
  • 1,800 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Intact Investment Management's 13F filing for Q2 2026, filed 20 Jul 2026.